Staff turnover in EUR-----
Staff turnover in EUR-----
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)0.000.000.00116.110.00
Dividend per share-----
Basic earnings per share-0.71-0.90-0.91-1.01-3.19
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover0.00.00.00.00.0
Operating income (EBIT)-47.9-60.5-86.7-129.6-338.0
Earnings before taxes-55.0-68.9-85.9-110.0-359.6
Annual net profit/ loss-55.0-68.9-85.9-110.0-359.6
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets210.5167.0367.2907.2715.6
Total fixed assets0.11.51.31.10.1
Total assets210.7168.5368.5908.3715.7
Liabilities
Total short-term liabilities8.821.919.127.476.7
Total long-term liabilities0.01.30.90.60.0
Total provisions0.00.00.00.00.0
Equity capital201.9145.3348.4880.3639.1
Total liabilities210.7168.5368.5908.3715.7
Management:
Lawson Macartney
S. Rouan
Charles Rowland
J. Singleton
Matthew Foehr
Brian Lian
Geoffrey Barker
Greg Zante
Marianne Mancini
Neil Aubuchon
Board:
Shareholding in %:
Address: 9920 Pacific Heights Boulevard, Suite 350, 92121 San Diego
T: +1-858-704-4660
F: +
I: http://www.vikingtherapeutics.com
E: [email protected]